89bio Inc

NASDAQ:ETNB   1:28:21 PM EDT
19.20
+0.04 (+0.21%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

89bio Inc Stock, NASDAQ:ETNB

142 Sansome Street, 2nd floor, San Francisco, California 94104
United States of America
Phone: +1.415.500.4614
Number of Employees: 27

Description

89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases. The firm product candidates and pipeline include BIO89-100, FGF21, NASH, and SHTG. The company was founded on January 01, 2018 and is headquartered in San Francisco, CA.